Patient Demographics (n = 61)
| Characteristic | Data |
|---|---|
| Median age (y) | 67.8 (range, 51–84) |
| ISUP grade | |
| 1 | 5 (8.2%) |
| 2 | 6 (9.8%) |
| 3 | 9 (14.8%) |
| 4 | 15 (24.6%) |
| 5 | 25 (41.0%) |
| Not available | 1 (1.6%) |
| Initial treatment | |
| None | 7 (11.5%) |
| Surgery (prostatectomy +/− lymph node dissection) | 28 (45.9%) |
| Definitive radiation therapy +/− ADT | 12 (19.6%) |
| ADT | 7 (11.5%) |
| ADT + chemotherapy | 5 (8.2%) |
| Cryotherapy | 2 (3.3%) |
| Castration status | |
| Castration-sensitive | 41 (67.3%) |
| Castration-resistant | 20 (32.7%) |
| Median PSA (ng/mL) | 9.97 (range 0.02–7270.8) |
| Median PSA doubling time (months) | 5.1 (range 0.7–81.7) |
| Median PSA velocity (ng/mL/y) | 15.4 (range 0.1–5967.4) |
| Therapy at time of imaging | |
| No treatment | 34 (55.7%) |
| ADT | 18 (29.5%) |
| ADT + other | 3 (4.9%) |
| Other (chemotherapy, immunotherapy, estradiol patch) | 6 (9.8%) |
ISUP = International Society of Urological Pathologists.